Molecular Characterization of Carbapenemase (Blakpc-2) Gene From Klebsiella Pneumoniae Involved in Urinary Tract Infection in Al-Najaf City
DOI:
https://doi.org/10.46966/msjar.v5i3.223Keywords:
K. pneumoniae, Carbapenemases, KPC, Cloning, SequencingAbstract
Background: The human gastrointestinal tract, eyes, respiratory system, and genitourinary tract are all home to K. pneumonia. KPCs, or Klebsiella pneumonia carbapenemases, are β-lactamase enzyme types that have the ability to hydrolyze β-lactam drugs. Because of many co-morbid diseases, immunological suppression, and critical sickness, this KPC-producing strain infection can be fatal. In this study K. pneumonia was isolated from urinary tract infected patients, Where seven clinical urine specimen obtained from patients has UTI were gathered from different diagnostic Al-Sajjad Hospital in Najaf province the KPC gene was amplified by PCR. In this present study, a particular primer derived from the antibiotic sensitivity (blaKPC-2) gene is used to screen the urine samples collected for Klebsiella pneumoniae stains utilizing culture techniques then sequence analysis of the blaKPC-2 gene was conducted in order to gain a fresh understanding of the genetic variations. It's interesting to note that, while comparing our strains' blaKPC-2 open reading frame to previously released sequences, we discovered 6 mutations. Therefore, of the seven samples analyzed, three exhibited a positive band. The purpose of the primer was to amplify the bacteria's blaKPC-2 antibiotic sensitivity gene.
Conclusion: In this work, we verified a PCR technique for blaKPC-2 gene identification that is quick, sensitive, and specific. Out of the seven samples analyzed, three exhibited a positive band. The purpose of the primer was to amplify the bacteria's blaKPC-2 antibiotic sensitivity gene.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Najat Mohammed Flyyih, Alaa Hashim Abd Ali, Ameer Abood Karim Al-Rammah
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
